Mint Tower Capital Management’s Boston Scientific BSX Stock Holding History

Mint Tower Capital Management’s Portfolio BSX Stock Details BSX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q1	–	Sell	-37,500	Closed	-$1.59M	–	345
2021 Q4	$1.59M	Sell	37,500 -2,500	-6%	-$105K	0.2%	101
2021 Q3	$1.74M	Hold	40,000	–	–	0.22%	94
2021 Q2	$1.71M	Buy	+40,000	New	+$1.68M	0.12%	140

Other funds holding BSX

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Massachusetts Financial Services Boston, Massachusetts $298B AUM 21.96% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return

Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return

Bollard Group Boston, Massachusetts $3.39B AUM 1.06% 1-Year Est. Return

Mint Tower Capital Management's BSX Position: Q3 2021 in Review

Mint Tower Capital Management sold out of Boston Scientific (BSX) in Q3 2021, closing a stake of 3,262 shares — an estimated $144K sold.

Mint Tower Capital Management first reported a position in BSX in Q2 2021 and held it in 1 quarter. The position peaked at $139K in Q2 2021. 877 funds tracked by Wall St. Rank hold BSX as of Q3 2021.

Mint Tower Capital Management reported no remaining Boston Scientific position as of Q3 2021 after selling out during the quarter.
Mint Tower Capital Management sold 3,262 Boston Scientific shares in Q3 2021, an estimated $144K.
Mint Tower Capital Management first reported a position in Boston Scientific in Q2 2021 and held it in 1 quarter.
Mint Tower Capital Management's Boston Scientific position peaked at $139K in Q2 2021.
877 funds tracked by Wall St. Rank held Boston Scientific as of Q3 2021.

Based on Mint Tower Capital Management's 13F filing for Q3 2021, filed 16 Nov 2021.